Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL6082805 | 1.00 | LMNA (0.43) | LMNAALDH1A1USP2CYP1A2TSHR | |
| Acrylic Acid SCHEMBL3269801 | 1.00 | LMNA (0.43) | LMNAALDH1A1USP2CYP1A2TSHR | |
| Acrylic Acid SCHEMBL29564449 | 1.00 | LMNA (0.43) | LMNAALDH1A1USP2CYP1A2TSHR | |
| Acrylic Acid SCHEMBL30580736 | 1.00 | LMNA (0.43) | LMNAALDH1A1USP2CYP1A2TSHR | |
| Acrylic Acid SCHEMBL16532 | 1.00 | LMNA (0.43) | LMNAALDH1A1USP2CYP1A2TSHR | |
| Acrylic Acid SCHEMBL1144760 | 1.00 | LMNA (0.43) | LMNAALDH1A1USP2CYP1A2TSHR | |
| Acrylic Acid SCHEMBL31493176 | 1.00 | LMNA (0.43) | LMNAALDH1A1USP2CYP1A2TSHR | |
| Acrylic Acid SCHEMBL29386496 | 1.00 | LMNA (0.43) | LMNAALDH1A1USP2CYP1A2TSHR | |
| Acrylic Acid SCHEMBL4923300 | 1.00 | LMNA (0.43) | LMNAALDH1A1USP2CYP1A2TSHR | |
| Acrylic Acid SCHEMBL2458601 | 1.00 | LMNA (0.43) | LMNAALDH1A1USP2CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11576998-B2 | High refractive index, high Abbe number intraocular lens materials | ALCON INC. (CH) | 2023-02-14 | — | — | US | claimed |
| EP-3634508-B1 | HIGH REFRACTIVE INDEX, HIGH ABBE NUMBER INTRAOCULAR LENS MATERIALS | ALCON INC (CH) | 2021-10-27 | — | — | EP | claimed |
| EP-2302011-B1 | Curable gel inks with reduced syneresis and halo formation | XEROX CORP (US) | 2014-07-09 | — | — | EP | claimed |
| US-20260147141-A1 | SURFACE MODIFIED SILICONE OPHTHALMIC DEVICES | BAUSCH + LOMB IRELAND LIMITED (IE) | 2026-05-28 | — | — | US | disclosed |
| US-20260078209-A1 | SILICONE HYDROGEL INK BINDER FOR CONTACT LENSES | BAUSCH & LOMB IRELAND LTD (IE) | 2026-03-19 | — | — | US | disclosed |
| EP-4683963-A1 | SILICONE HYDROGELS | Bausch + Lomb Ireland Limited (IE) | 2026-01-28 | — | — | EP | disclosed |
| EP-4683962-A1 | MONOFUNCTIONAL SILICONE MONOMERS AND SILICONE HYDROGELS FORMED THEREFROM | Bausch + Lomb Ireland Limited (IE) | 2026-01-28 | — | — | EP | disclosed |
| EP-4677398-A1 | CONTACT LENS CONTAINING DEPROTECTED ULTRAVIOLET BLOCKERS | Bausch + Lomb Ireland Limited (IE) | 2026-01-14 | — | — | EP | disclosed |
| EP-4654920-A1 | OPHTHALMIC DEVICES HAVING A HIGH REFRACTIVE INDEX AND ABBE NUMBER | Bausch + Lomb Ireland Limited (IE) | 2025-12-03 | — | — | EP | disclosed |
| US-20250334718-A1 | SURFACE MODIFIED SILICONE OPHTHALMIC DEVICE | BAUSCH & LOMB IRELAND LTD (IE) | 2025-10-30 | — | — | US | disclosed |
| WO-2025093198-A1 | VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC DEVICES | BAUSCH + LOMB IRELAND LIMITED (IE) | 2025-05-08 | — | — | WO | disclosed |
| US-20240317988-A1 | MONOFUNCTIONAL SILICONE MONOMERS AND SILICONE HYDROGELS FORMED THEREFROM | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2024-09-26 | — | — | US | disclosed |
| WO-2024193880-A1 | MONOFUNCTIONAL SILICONE MONOMERS AND SILICONE HYDROGELS FORMED THEREFROM | BAUSCH + LOMB IRELAND LIMITED (IE) | 2024-09-26 | — | — | WO | disclosed |
| US-20240317943-A1 | SILICONE HYDROGELS | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2024-09-26 | — | — | US | disclosed |
| WO-2024193881-A1 | SILICONE HYDROGELS | BAUSCH + LOMB IRELAND LIMITED (IE) | 2024-09-26 | — | — | WO | disclosed |
| US-20240302569-A1 | CONTACT LENS CONTAINING DEPROTECTED ULTRAVIOLET BLOCKERS | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2024-09-12 | — | — | US | disclosed |
| WO-2024183985-A1 | CONTACT LENS CONTAINING DEPROTECTED ULTRAVIOLET BLOCKERS | BAUSCH + LOMB IRELAND LIMITED (IE) | 2024-09-12 | — | — | WO | disclosed |
| US-20240277895-A1 | OPHTHALMIC DEVICES HAVING A HIGH REFRACTIVE INDEX AND ABBE NUMBER | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2024-08-22 | — | — | US | disclosed |
| WO-2024156667-A1 | OPHTHALMIC DEVICES HAVING A HIGH REFRACTIVE INDEX AND ABBE NUMBER | BAUSCH + LOMB IRELAND LIMITED (IE) | 2024-08-02 | — | — | WO | disclosed |
| US-11576998-B2 | High refractive index, high Abbe number intraocular lens materials | ALCON INC. (CH) | 2023-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078209-A1 | SILICONE HYDROGEL INK BINDER FOR CONTACT LENSES | CRYAA, CRYAB, CRYZ | LMNA 2144/4885ALDH1A1 2751/4885USP2 2017/4885 |
| US-20240317988-A1 | MONOFUNCTIONAL SILICONE MONOMERS AND SILICONE HYDROGELS FORMED THEREFROM | F12, RAD51, CHRM1 | LMNA 1624/4885ALDH1A1 1663/4885USP2 1034/4885 |
| US-20260147141-A1 | SURFACE MODIFIED SILICONE OPHTHALMIC DEVICES | EPCAM, STIM1, SMCHD1 | LMNA 2741/4885ALDH1A1 2187/4885USP2 1732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.